Sort
30,917 grants matching “tumor microenvironment”
Defining and targeting epigenetic plasticity-driven drug resistance and immune escape in melanoma
$463,483Keiran Smalley · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2024 · CA
Modulation of tumor inflammatory factor for immune therapy
$463,463Shu-Hsia Chen · Methodist Hospital Research Institute · R01 · FY2018 · CA
Modulation of tumor inflammatory factor for immune therapy
$463,463Shu-Hsia Chen · Methodist Hospital Research Institute · R01 · FY2021 · CA
Modulation of tumor inflammatory factor for immune therapy
$463,463Shu-Hsia Chen · Methodist Hospital Research Institute · R01 · FY2020 · CA
Identification and validation of synthetic lethality in KRAS mutant lung adenocarcinoma patient derived xenografts
$463,415Charles M Rudin · Sloan-Kettering Inst Can Research · U01 · FY2019 · CA
Core C: Pathology, Biospecimen and Immune Profiling
$463,372Tamara Levin Lotan · University Of Southern California · U19 · FY2022 · CA
PDGF-BB and the metastatic brain microenvironment
$463,292Gina Marie Sizemore · Ohio State University · R37 · FY2025 · CA
Remodeling of Lymph Node-Derived Cytokine Responses at the Infected Tissue Site
$463,271Deborah J Fowell · Cornell University · R37 · FY2023 · AI
ALL immunobiology and the bone marrow niche
$463,229Terry Fry · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Causes and Consequences of Acid pH in Tumors
$463,130Robert J Gillies · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2011 · CA
Comprehensive characterization of prostate stromal gene expression and association with lethal prostate cancer
$463,114Kathryn L Penney · Brigham And Women'S Hospital · R37 · FY2021 · CA
Drug-Loaded Nanobubbles for Ultrasound Enhanced Delivery to Colon Cancer Liver Metastasis
$463,093Agata A Exner · Case Western Reserve University · R01 · FY2022 · EB
Drug-Loaded Nanobubbles for Ultrasound Enhanced Delivery to Colon Cancer Liver Metastasis
$463,093Agata A Exner · Case Western Reserve University · R01 · FY2023 · EB
Predictive and Diagnostic Radiomic Signatures in Non-Small Cell Lung Cancer (NSCLC)on Immunotherapy
$463,067Despina Kontos · Columbia University Health Sciences · R01 · FY2024 · CA
Reengineering obesity-induced abnormal microenvironment to improve PDAC treatment
$463,057Dai Fukumura · Massachusetts General Hospital · R01 · FY2019 · CA
Targeting stem-like cells and their niche in pancreatic cancer
$463,044Tuomas Tammela · Sloan-Kettering Inst Can Research · R37 · FY2024 · CA
Project 2: Investigating cell intrinsic and extrinsic drivers of prostate cancer bone metastasis
$462,982Cory Abate-Shen · Columbia University Health Sciences · P01 · FY2024 · CA
Modeling Response to HER2 target therapies
$462,960Joe W. Gray · Oregon Health & Science University · U54 · FY2013 · CA
Metastatic Clonal Heterogeneity and its Impact on Melanoma Therapeutic Resistance
$462,960Willy Hugo · University Of California Los Angeles · R01 · FY2022 · CA
Metastatic Clonal Heterogeneity and its Impact on Melanoma Therapeutic Resistance
$462,960Willy Hugo · University Of California Los Angeles · R01 · FY2021 · CA
Mapping cancer micro-environments for acute leukemia
$462,880Iannis Aifantis · New York University School Of Medicine · R01 · FY2017 · CA
Understanding the influence of bone-metastatic prostate cancer and mesenchymal stromal cells on γδ T cells, in the bone microenvironment.
$462,850Daniel Abate-Daga · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2023 · CA
Core D: Pathology and BioImaging
$462,848Carl D Morrison · Roswell Park Cancer Institute Corp · P01 · FY2021 · CA
Decoding tobacco-related oral cancer ecosystem by integrative approach
$462,811Aik Choon Tan · University Of Utah · R01 · FY2022 · DE
An Environmental Chemical Receptor, the AhR, as a Mediator of Multiple Immune Checkpoints in Oral Cancer
$462,785David H Sherr · Boston University Medical Campus · R01 · FY2022 · ES